Cymbalta Adds Musculoskeletal Pain Claim Despite Advisory Committee Concerns
This article was originally published in The Pink Sheet Daily
Executive Summary
Label for duloxetine's new use emphasizes that efficacy was shown only in patients with chronic lower back pain and osteoarthritis.